Repertoire Immune Medicines

Repertoire Immune Medicines

  • Founded: 2017
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: RD
  • Therapy area: Melanoma
  • Drug types: ONC, NEU, IMM, END
  • Lead product: DECODE platform
  • Product link:
  • Funding: $189M B Apr 2021

job board

Short description:

Cell & Peptide-Based Therapies

Drug notes:

Also RD MS, diabetes (1), undisclosed

Long description:

Repertoire Immune Medicines is developing ways to activate the human immune response to prevent, treat and cure cancer and autoimmune conditions. Understanding the elegance of the human immune system will enable much innovation in medicinal science. This is the belief of Repertoire as they exploit the power of T cells to create a new class of medicines. Repertoire is understanding the interface between T cells and cells that present an intracellular antigen by using their proprietary DECODE platform. DECODE generates insights into operations of the immune system that enables the development of more precise medicines. Repertoire’s lead products are at clinical stage for patients with melanomas.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy